Skip to content

Effect of Non Invasive Ventilation on Lung Volumes Determined by Electrical Impedance Tomography

Effect of Non Invasive Ventilation on Lung Volumes Determined by Electrical Impedance Tomography

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02150018
Acronym
NIVIT
Enrollment
20
Registered
2014-05-29
Start date
2014-06-30
Completion date
2015-12-31
Last updated
2015-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

- Critical Care, Electrical Impedance Tomography, End Expiratory Lung Impedance, End Expiratory Lung Volume, Non Invasive Ventilation

Keywords

- Critical Care, Non invasive ventilation, Electrical impedance tomography, End expiratory lung volume, End expiratory lung impedance

Brief summary

Effect of Non Invasive Ventilation on end-expiratory lung volumes determined by electrical impedance tomography

Detailed description

Prospective clinical study in ICU with patients requiring non invasive ventilation (NIV) comparing lung volumes determined by electrical impedance tomography before, during and after NIV. Duration of NIV is 30 minutes.

Interventions

OTHERnon invasive ventilation

Sponsors

University Hospital, Estaing
CollaboratorOTHER
University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult ICU patients requiring non invasive ventilation * Consent of patients or family * Arterial line

Exclusion criteria

* Tracheotomized patients * Dressings in the thoracic area

Design outcomes

Primary

MeasureTime frame
- End-expiratory lung volume (EELV) determined by electrical impedance tomography before, during and after NIVat day 1

Secondary

MeasureTime frame
Anterior, medio-anterior, medio-posterior and posterior EELVat day 1
Ventilatory frequencyat day 1

Countries

France

Contacts

Primary ContactPatrick LACARIN
placarin@chu-clermontferrand.fr04 73 75 11 95

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026